Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ONC
$347.48
-2.40%
ONC · BeOne Medicines Ltd.
$347.48
-8.53 (-2.40%)
At close · Aug 14
Market Cap
$513.62B
Shares
1.48B
All earnings calls
Earnings call · FY2024 Q4
BeOne Medicines Ltd. Q4 FY2024 Earnings Call
BeOne Medicines Ltd. Q4 FY2024 Earnings Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$1.13B
+77.8% YoY
Gross margin · derived Q4
85.8%
+2.5 pp YoY
Net income · derived Q4
-$151.88M
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
13 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Feb 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 28, 2025 · complete as-filed document